KV Purchases Hologic Premature Birth Prevention Candidate; Sale Contingent On FDA Approval
NDA approval is expected in late 2008 for Gestiva, which has been under review since April 2006.
NDA approval is expected in late 2008 for Gestiva, which has been under review since April 2006.